Arrow Exploration (AXL) announced a further update on the Rio Cravo Sur-1 well located on the Tapir Block in the Llanos Basin of Colombia. Spud on May 23, 2022, the

Arrow Exploration (AXL) announced a further update on the Rio Cravo Sur-1 well located on the Tapir Block in the Llanos Basin of Colombia. Spud on May 23, 2022, the
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Arc, Arrow, Caerus, Cornish, Cleantech, Clontarf,
Caerus Mineral Resources (CMRS), the Cyprus-based exploration and resource development company, updated on exploration activities on the Kambia – Kapedes Project Licences in Cyprus.
Another day, another update from Open Orphan (ORPH), a specialist contract research organisation, as it announced that hVIVO, a subsidiary of Open Orphan, has been awarded a new study with
Shares of Iamfire (FIRE) may be in focus to start the shortened trading week, in the wake of a gala presentation of investee company WeShop at Claridge’s on Friday. The
Poolbeg Pharma (POLB), a clinical stage infectious disease pharmaceutical company, announced the results of the proposal from a number of New Investors to purchase shares from distribution in specie shareholders
Xtract Resources (XTR) report on three further drill holes completed in the area between Racecourse and Ascot on the Bushranger copper-gold porphyry exploration project.
The fightback continues at DeepVerge (DVRG), as the first six installations of Modern Water Post-Pandemic Microtox®PD pathogen detection systems in wastewater have been deployed to various sites in the UK
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection includes Amte, Amur, Berkeley, Bens, Caerus, Conroy, Eurasia, Hemo,
Market newbie Genflow (GENF) gets its newsflow going in earnest as it announces that its subsidiary, Genflow Biosciences SRL, has received a non-dilutive research grant award of up to €3.375m
Business would appear to be booming at Kromek Group (KMK), a leading developer of radiation and bio-detection technology solutions as it announced its interim results for the six months ended